Monthly Archives: October 2011

The Big Shortage—Where Have All the Drugs Gone?

By Jessica Wapner
Posted: October 19, 2011

Category: Drug Shortage | Tagged breast cancer, Dana-Farber Cancer Institute, daunorubicin, Doxil, doxorubicin, drug shortage, generic drugs, gray market, idarubicin, leukemia, Seattle Cancer Care Alliance, The Why Files | 2 Comments

and now for something completely different

By Jessica Wapner
Posted: October 14, 2011

Category: Off Topic | Tagged Catherine chalmers, Imagine Science Films, leaf-cutter ants | Leave a comment

The Many Reasons Why Personalized Medicine Is So Tricky

By Jessica Wapner
Posted: October 12, 2011

Category: cancer | Tagged BOLERO-2, breast cancer, cancer, European Multidisciplinary Cancer Congress, everolimus, gene sequencing, Gordon Mills, hormone therapy, M. D. Anderson Cancer Center, mTOR inhibitors, personalized medicine, targeted therapy | Leave a comment

More on Cancer Cost: Toxicities

By Jessica Wapner
Posted: October 3, 2011

Category: cancer | Tagged adverse events, anemia, cancer, dyspnea, European Multidisciplinary Cancer Congress, Genentech, Herceptin, lapatinib, neutropenia, side effects, toxicities, trastuzumab, Tykerb | Leave a comment